In a systematic retrospective study the authors reviewed charts of 22
depressed children on a clinical research unit who were withdrawn from
high-dose imipramine. Significant withdrawal symptoms were found over seven
symptom categories despite an average tapering period of 6.4 days. These
results suggest that withdrawal symptoms in children may be much more
prevalent and intense than previously recognized.